Evidence map›Paper›PMID 39336418›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case-Control Study from Astana, Kazakhstan.

Kristina Rutskaya-Moroshan, Saule Abisheva, Anilim Abisheva, Zhadra Amangeldiyeva, Tatyana Vinnik, Tansholpan Batyrkhan

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristina Rutskaya-MoroshanDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.ORCID 0000-0002-9324-8720
Saule AbishevaDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.ORCID 0000-0001-6260-8220
Anilim AbishevaDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.
Zhadra AmangeldiyevaDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.
Tatyana VinnikDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.
Tansholpan BatyrkhanDepartment of Family Medicine №1, NJSC «Astana Medical University», Astana 010000, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Rheumatic DiseasesAdultAgedAutoimmune DiseasesCase-Control StudiesFemaleHumansKazakhstanMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsSARS-CoV-2Severity of Illness Indexautoimmune diseasesdisease coursedisease-modifying antirheumatic drugsprognostic factorsSARS-CoV-2 infection

Identifiers

PMID39336418
PMCPMC11433992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.